Supplement
Umckaloabo is a herbal extract made from the roots of Pelargonium sidoides, a South African geranium, traditionally used for chest and airway complaints and thought to influence how the body responds to respiratory infections. People mostly look at it for bronchitis, and the evidence is strong: pooled trials, including one in children and adolescents, found bronchitis symptoms improved. Smaller studies pointed to eased asthma symptoms during colds, but that rests on a single trial of 61 children, so it is limited.
Sources: PMID 18222667; PMID 22360575
- Updated
- How we grade
- 22 studies cited
- Best evidence
- Grade A
- Conditions studied
- 9
- Outcomes
- 42
- Graded outcomes
- 3321
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Acute Bronchitis
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bronchitis Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 4 studies | 644 people | ||
Studies that measured bronchitis symptoms
| ||||||
| Fever | Improves (the measure goes up) | 2 studies | 131 people | |||
Studies that measured fever | ||||||
| Common Cold Symptoms | Improves (the measure goes down) | 1 study | 832 people | |||
Studies that measured common cold symptoms | ||||||
| Cough | Changes; see studies | 1 study | 746 people | |||
Studies that measured cough | ||||||
| Nasal Congestion | Improves (the measure goes up) | 1 study | 131 people | |||
Studies that measured nasal congestion | ||||||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 1 study | 28 people | |||
| Headaches | Improves (the measure goes down) | 103 people | ||||
Acute Bronchitis
- Bronchitis Symptoms: improves
- Appetite: worsens
- Lung Function: improves
Acute Respiratory Infection (ARI)
- Bronchitis Symptoms: improves
- Common Cold Symptoms: improves
- Nasal Congestion: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bronchitis Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 4 studies | 341 people | ||
Studies that measured bronchitis symptoms
| ||||||
| Common Cold Symptoms | Improves (the measure goes down) | 1 study | 1,771 people | |||
Studies that measured common cold symptoms | ||||||
| Nasal Congestion | Improves (the measure goes up) | 1 study | 1,771 people | |||
Studies that measured nasal congestion | ||||||
| Upper Respiratory Tract Infection Symptoms | Improves (the measure goes down) | 1 study | 990 people | |||
Studies that measured upper respiratory tract infection symptoms | ||||||
Upper Respiratory Tract Infection
- Asthma Symptoms: improves
- Fever: improves
- Cough: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asthma Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 61 people | ||
Studies that measured asthma symptoms | ||||||
| Fever | Improves (the measure goes up) | 2 studies | 61 people | |||
Studies that measured fever | ||||||
| Cough | Changes; see studies | 1 study | 746 people | |||
Studies that measured cough | ||||||
| Nasal Congestion | Improves (the measure goes up) | 1 study | 61 people | |||
Studies that measured nasal congestion | ||||||
Immune Health
- Exercise-Induced Immune Suppression: improves
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise-Induced Immune Suppression Small Improvement | Improves (the measure goes up) | Small effect | 25 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 25 people | |||
Aerobic Exercise Performance
- Aerobic Exercise Metrics
- Immunoglobulin A: improves
- Exercise-Induced Immune Suppression: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Aerobic Exercise Metrics No effect | NoneNo effect | 25 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 25 people | |||
| Exercise-Induced Immune Suppression | Improves (the measure goes up) | 25 people | ||||
Chronic Obstructive Pulmonary Disease (COPD)
- Lung Function: improves
Sinusitis
- Nasal Congestion: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Nasal Congestion | Improves (the measure goes up) | 1 study | 203 people | |||
Studies that measured nasal congestion | ||||||
Key findings
- Bronchitis SymptomsImproves (the measure goes down)
- AppetiteWorsens (the measure goes up)
- Asthma SymptomsImproves (the measure goes down)
Shop the evidence-backed picks
Third-party tested Umckaloabo products, in the forms the graded studies used where we can match them.
- Grade A
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
22 studies from PubMed
- Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial
- EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial
- Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children
- Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis
- Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides
- EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitis
- Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study
- Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial
- Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots
- Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis
- Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents
- Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life - a meta-analysis of randomized, placebo-controlled trials.
- Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial
- Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children
- Herbal Medicine for Cough: a Systematic Review and Meta-Analysis.
- Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD
- Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial
- The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy
- Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis.
- Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15
- Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis.
- Pelargonium sidoides extract for treating acute respiratory tract infections.